Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, Nijmegen.
Department of Neurology, Amphia Hospital, Breda, the Netherlands.
Dev Med Child Neurol. 2021 Aug;63(8):963-968. doi: 10.1111/dmcn.14852. Epub 2021 Mar 10.
To provide insight into outcome and long-term safety and efficacy of deep brain stimulation (DBS), from the perspective of individuals with Lesch-Nyhan disease (LND) and their families.
We used patient-centered outcome measures to assess long-term outcomes of DBS for 14 individuals (mean [SD] age 10y 10mo [5y 6mo], range 5-23y, all males) with LND, after an average duration of 5y 6mo (range 11mo-10y 5mo) after surgery. We compared these results with a comprehensive review of previously published cases.
Patients and their families reported that DBS of the globus pallidus can be effective both for motor and behavioral disturbances in LND. However, outcome measures were often not significantly changed owing to substantial variability among individuals, and were overall less positive than in previous reports based on clinician assessments. In addition, there was an unexpectedly high rate of adverse events, tempering overall enthusiasm for the procedure.
Although DBS might be an effective treatment for LND, more research is needed to understand the reasons for response variability and the unusually high rates of adverse events before DBS can be recommended for these patients. What this paper adds Individuals with Lesch-Nyhan disease and their families report variable efficacy of deep brain stimulation. Long-term outcomes are associated with a high adverse event rate.
从患有莱施-尼汉病(Lesch-Nyhan disease,LND)的个体及其家庭的角度,深入了解深部脑刺激(DBS)的结果和长期安全性及疗效。
我们使用以患者为中心的结局评估指标,评估了 14 名 LND 患者(平均[标准差]年龄 10 岁 10 个月[5 岁 6 个月],年龄范围 5-23 岁,均为男性)接受 DBS 治疗后的长期结局,手术平均随访 5 年 6 个月(11 个月-10 年 5 个月)。我们将这些结果与先前发表病例的综合回顾进行了比较。
患者及其家属报告称,苍白球 DBS 对 LND 的运动和行为障碍均有效。然而,由于个体之间存在较大的变异性,因此结局评估指标通常没有明显改变,且整体结果不如先前基于临床医生评估的报告积极。此外,不良事件的发生率出乎意料地高,这降低了对该手术的整体热情。
尽管 DBS 可能是 LND 的有效治疗方法,但在推荐 DBS 用于这些患者之前,还需要开展更多研究以了解反应变异性的原因以及不良事件发生率高的原因。
患有莱施-尼汉病的个体及其家属报告称,深部脑刺激的疗效存在差异。长期结局与高不良事件发生率相关。